Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Signaling Pathways Explain Kidney Growth
Scientific Advances

Signaling Pathways Explain Kidney Growth

By Office of CommunicationsJun 4, 2015
Share
Facebook Twitter Email
Dean Eric Neilson
Eric G. Neilson, MD, vice president for Medical Affairs and Lewis Landsberg Dean, coauthored a new paper revealing the complex biochemical mechanisms underlying renal hypertrophy.

Kidney mass increases or adapts to growing body mass by the time we achieve early adulthood. When the body loses one kidney—from trauma, injury or donating a kidney—the remaining kidney also enlarges to maintain the requirements for glomerular filtration. These changes in kidney size are the result of renal hypertrophy.

Eric G. Neilson, MD, vice president for Medical Affairs and Lewis Landsberg Dean, coauthored a new paper, published recently in the Journal of Clinical Investigation, which reveals the biochemical mechanisms underlying kidney hypertrophy.

Hypertrophy happens when the cells in an organ individually increase their size. The new study demonstrates that pathways involving the mTOR complex activate both modes of kidney enlargement. However, unique molecular signaling of that pathway depends on context.

Through a series of complex experiments, the authors showed during normal maturation that receptor tyrosine kinases on proximal tubular cells activate class I PI3K/PTEN to regulate an MTORC1/lysosomal effect on protein synthesis leading to adaptive hypertrophy.

Alternatively, after the loss of a kidney, blood flow to the remaining kidney increases, delivering more amino acids to the organ than before. This amino acid load activates class III PI3K enzymes and vesicular trafficking to lysosomes that also activates MTORC1. The class III PI3K pathway likely explains why kidneys grow bigger when people consume high-protein diets or develop diabetes.

“We now have good answers for century-old questions,” said Dr. Neilson, who started the research when he was chairman of Medicine at Vanderbilt University School of Medicine. “The answers are important because the precise biochemical signaling for renal hypertrophy has been uncertain and because that signaling can trigger or accelerate chronic kidney diseases. Knowing the different molecular pathways for hypertrophy also potentially offers new drugable targets that may be helpful someday for patients who are at risk for unwanted hypertrophy.”

Dr. Neilson collaborated with scientists from Vanderbilt, the Medical College of Georgia at Georgia Regents University and Texas A&M University on this work.

“The same common mechanism—activation of the mTOR complex—leads to hypertrophy, but how you get there is different for normal adaptation of kidney size or for the remarkable compensatory growth after loss of one kidney,” said coauthor Raymond Harris, MD, chief of Nephrology and Hypertension at Vanderbilt.

The work was supported by National Institutes of Health (NIH) grants DK83575, DK38226, DK51265 and DK46282; American Heart Association Scientist Development Grant 0630274N; start-up funds from Georgia Regents University Augusta; a VA Merit Award; the Mochida Memorial Foundation for Medical and Pharmaceutical Research; the Uehara Memorial Foundation; and Grant-in-Aid for Research Activity Start-up from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Biochemistry Research
Share. Facebook Twitter Email

Related Posts

Weight Loss Drug May Help Patients with Heart Failure

Oct 2, 2023

Surmeier Recognized with Annemarie Opprecht Parkinson Award

Oct 2, 2023

Mapping Neural Activity Patterns and Odor Perception  

Sep 28, 2023

Comments are closed.

Latest News

Weight Loss Drug May Help Patients with Heart Failure

Oct 2, 2023

Surmeier Recognized with Annemarie Opprecht Parkinson Award

Oct 2, 2023

Medical Education Day Celebrates Mentorship and Equity

Sep 29, 2023

Mapping Neural Activity Patterns and Odor Perception  

Sep 28, 2023

Lloyd-Jones Announces He is Stepping Down as Chair of Preventive Medicine

Sep 27, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230927_MedEdDay_Sargent_6
20230927_MedEdDay_Sargent_3
20230927_MedEdDay_Sargent_1
20230927_MedEdDay_Posters_Patel_2
20230927_MedEdDay_Posters_Patel_1
20230927_MedEdDay_Posters_Panko_1
20230927_MedEdDay_Posters_4
20230927_MedEdDay_Posters_3
20230927_MedEdDay_Posters_2
20230927_MedEdDay_Posters_1
20230927_MedEdDay_Awards_6
20230927_MedEdDay_Awards_5

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.